133 related articles for article (PubMed ID: 34452864)
1. Perceptions of Role in Treatment Decision Making and Understanding of Late Effects Among Hodgkin Lymphoma Survivors: Results From a National Survey HL Decision Making and Late Effects.
Kumar AJ; Murphy-Banks R; Weidner RA; Parsons SK
Clin Lymphoma Myeloma Leuk; 2022 Jan; 22(1):e65-e69. PubMed ID: 34452864
[TBL] [Abstract][Full Text] [Related]
2. Hodgkin lymphoma survivor perspectives on their engagement in treatment decision-making and discussion of late effects.
Murphy-Banks R; Kumar AJ; Lin M; Savidge N; Livne E; Parsons SK
Support Care Cancer; 2022 Feb; 30(2):1399-1405. PubMed ID: 34524526
[TBL] [Abstract][Full Text] [Related]
3. Patient-Reported Survivorship Care Practices and Late Effects After Treatment of Hodgkin and Non-Hodgkin Lymphoma.
Frick MA; Vachani CC; Hampshire MK; Bach C; Arnold-Korzeniowski K; Metz JM; Hill-Kayser CE
JCO Clin Cancer Inform; 2018 Dec; 2():1-10. PubMed ID: 30652594
[TBL] [Abstract][Full Text] [Related]
4. Effectiveness and Cost-Effectiveness of Survivorship Care for Survivors of Hodgkin Lymphoma (INSIGHT Study): Protocol for a Multicenter Retrospective Cohort Study With a Quasi-Experimental Design.
Lammers EMJ; Zijlstra JM; Retèl VP; Aleman BMP; van Leeuwen FE; Nijdam A;
JMIR Res Protoc; 2024 Apr; 13():e55601. PubMed ID: 38635308
[TBL] [Abstract][Full Text] [Related]
5. The development of a decision aid to support Hodgkin lymphoma survivors considering lung cancer screening.
Broadbent R; Seale T; Armitage CJ; Linton K
BMC Med Inform Decis Mak; 2022 Feb; 22(1):29. PubMed ID: 35105364
[TBL] [Abstract][Full Text] [Related]
6. Pediatric and Adolescent Hodgkin Lymphoma: Paving the Way for Standards of Care and Shared Decision Making.
Kahn JM; Mauz-Korholz C; Hernandez T; Milgrom SA; Castellino SM
Am Soc Clin Oncol Educ Book; 2024 Jun; 44(3):e432420. PubMed ID: 38788179
[TBL] [Abstract][Full Text] [Related]
7. [The BETER survivorship care initiative for Hodgkin lymphoma; tailored survivorship care for late effects of treatment].
Dekker N; van 't Veer MB; Aleman BM; van Leeuwen FE; Raemaekers JM
Ned Tijdschr Geneeskd; 2015; 159():A9269. PubMed ID: 26577382
[TBL] [Abstract][Full Text] [Related]
8. Late-effect awareness and follow-up of cancer in general practice.
Eikeland SA; Smeland KB; Brekke M; Kiserud CE; Fosså A
Scand J Prim Health Care; 2022 Sep; 40(3):360-369. PubMed ID: 36380478
[TBL] [Abstract][Full Text] [Related]
9. Barriers to long-term follow-up in pediatric Hodgkin lymphoma survivors.
Tinsley H; Gramatges M; Dreyer Z; Okcu MF; Shakeel O
Pediatr Blood Cancer; 2024 Apr; 71(4):e30855. PubMed ID: 38200619
[TBL] [Abstract][Full Text] [Related]
10. Current survivorship recommendations for patients with Hodgkin lymphoma: focus on late effects.
Ng AK
Blood; 2014 Nov; 124(23):3373-9. PubMed ID: 25428219
[TBL] [Abstract][Full Text] [Related]
11. Employment status and health related quality of life among Hodgkin-lymphoma survivors'- results based on data from a major treatment center in Hungary.
Magyari F; Kósa K; Berecz R; Illés A; Miltényi Z; Simon Z; Illés Á
Health Qual Life Outcomes; 2017 Sep; 15(1):180. PubMed ID: 28927453
[TBL] [Abstract][Full Text] [Related]
12. Employment situation among long-term Hodgkin lymphoma survivors in Europe: an analysis of patients from nine consecutive EORTC-LYSA trials.
Juul SJ; Rossetti S; Kicinski M; van der Kaaij MAE; Giusti F; Meijnders P; Aleman BMP; Raemaekers JMM; Kluin-Nelemans HC; Spina M; Fermé C; Renaud L; Casasnovas O; Stamatoullas A; André M; Le Bras F; Plattel WJ; Henry-Amar M; Hutchings M; Maraldo MV
J Cancer Surviv; 2024 Jun; 18(3):727-738. PubMed ID: 36441393
[TBL] [Abstract][Full Text] [Related]
13. Patient-reported distress in Hodgkin lymphoma across the survivorship continuum.
Troy JD; Locke SC; Samsa GP; Feliciano J; Richhariya A; LeBlanc TW
Support Care Cancer; 2019 Jul; 27(7):2453-2462. PubMed ID: 30377801
[TBL] [Abstract][Full Text] [Related]
14. Late mortality, secondary malignancy and hospitalisation in teenage and young adult survivors of Hodgkin lymphoma: report of the Childhood/Adolescent/Young Adult Cancer Survivors Research Program and the BC Cancer Agency Centre for Lymphoid Cancer.
Bhuller KS; Zhang Y; Li D; Sehn LH; Goddard K; McBride ML; Rogers PC
Br J Haematol; 2016 Mar; 172(5):757-68. PubMed ID: 26727959
[TBL] [Abstract][Full Text] [Related]
15. Integration of Pediatric Hodgkin Lymphoma Treatment and Late Effects Guidelines: Seeing the Forest Beyond the Trees.
Ehrhardt MJ; Flerlage JE; Armenian SH; Castellino SM; Hodgson DC; Hudson MM
J Natl Compr Canc Netw; 2021 Jun; 19(6):755-764. PubMed ID: 34214967
[TBL] [Abstract][Full Text] [Related]
16. A qualitative systematic review of internal and external influences on shared decision-making in all health care settings.
Truglio-Londrigan M; Slyer JT; Singleton JK; Worral P
JBI Libr Syst Rev; 2012; 10(58):4633-4646. PubMed ID: 27820528
[TBL] [Abstract][Full Text] [Related]
17. The management of Hodgkin lymphoma in adolescents and young adults: burden of disease or burden of choice?
Flerlage JE; Metzger ML; Bhakta N
Blood; 2018 Jul; 132(4):376-384. PubMed ID: 29895665
[TBL] [Abstract][Full Text] [Related]
18. Hodgkin Lymphoma Survivor Wellness: Development of a Web-Based Intervention.
Amweg LN; McReynolds J; Lansang K; Jones T; Snow C; Berry DL; Partridge AH; Underhill-Blazey ML
Clin J Oncol Nurs; 2020 Jun; 24(3):284-289. PubMed ID: 32441674
[TBL] [Abstract][Full Text] [Related]
19. Risk of Second Cancer in Hodgkin Lymphoma Survivors and Influence of Family History.
Sud A; Thomsen H; Sundquist K; Houlston RS; Hemminki K
J Clin Oncol; 2017 May; 35(14):1584-1590. PubMed ID: 28384078
[TBL] [Abstract][Full Text] [Related]
20. Use of recommended posttreatment services for adolescent and young adult survivors of Hodgkin lymphoma.
Hahn EE; Wu YL; Munoz-Plaza CE; Garcia Delgadillo J; Cooper RM; Chao CR
Cancer; 2019 May; 125(9):1558-1567. PubMed ID: 30620388
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
